Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 47 条
  • [31] Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening
    Ibanez-Sanz, Gemma
    Garcia, Montse
    Rodriguez-Moranta, Francisco
    Binefa, Gemma
    Gomez-Matas, Javier
    Domenech, Xenia
    Vidal, Carmen
    Soriano, Antonio
    Moreno, Victor
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1249 - 1254
  • [32] Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial
    Hoffman, Richard M.
    Steel, Susan
    Yee, Ellen F. T.
    Massie, Larry
    Schrader, Ronald M.
    Murata, Glen H.
    PREVENTIVE MEDICINE, 2010, 50 (5-6) : 297 - 299
  • [33] Performance Characteristics and Comparison of Two Immunochemical and Two Guaiac Fecal Occult Blood Screening Tests for Colorectal Neoplasia
    Paul Rozen
    Judith Knaani
    Ziona Samuel
    Digestive Diseases and Sciences, 1997, 42 : 2064 - 2071
  • [34] Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia
    Rozen, P
    Knaani, J
    Samuel, Z
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (10) : 2064 - 2071
  • [35] Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
    Nyante, Sarah J.
    Black, Amanda
    Kreimer, Aimee R.
    Duggan, Maire A.
    Carreon, J. Daniel
    Kessel, Bruce
    Buys, Saundra S.
    Ragard, Lawrence R.
    Johnson, Karen A.
    Dunn, Barbara K.
    Lamerato, Lois
    Commins, John M.
    Berg, Christine D.
    Sherman, Mark E.
    GYNECOLOGIC ONCOLOGY, 2011, 120 (03) : 474 - 479
  • [36] Association Between Socioeconomic Status and Adherence to Fecal Occult Blood Tests in Colorectal Cancer Screening Programs: Systematic Review and Meta-Analysis of Observational Studies
    Luo, Zilin
    Dong, Xuesi
    Wang, Chenran
    Cao, Wei
    Zheng, Yadi
    Wu, Zheng
    Xu, Yongjie
    Zhao, Liang
    Wang, Fei
    Li, Jibin
    Ren, Jiansong
    Shi, Jufang
    Chen, Wanqing
    Li, Ni
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [37] Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening: Point-of-care tests are not tenable for a quality-assured Program
    Haug, Ulrike
    Becker, Nikolaus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (10) : 729 - U191
  • [38] Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening
    Tao, S.
    Haug, U.
    Kuhn, K.
    Brenner, H.
    BRITISH JOURNAL OF CANCER, 2012, 106 (08) : 1424 - 1430
  • [39] REHYDRATION OF GUAIAC-BASED FECAL OCCULT BLOOD-TESTS IN MASS-SCREENING FOR COLORECTAL-CANCER - AN ECONOMIC-PERSPECTIVE
    WALKER, AR
    WHYNES, DK
    HARDCASTLE, JD
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (02) : 215 - 218
  • [40] Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests
    Haug, Ulrike
    Hundt, Sabrina
    Brenner, Hermann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (03) : 682 - 690